New Delhi: Union Health Minister Harsh Vardhan said that late-stage clinical trials of intranasal COVID-19 vaccines are expected to be pursued by Serum Institute of India and Bharat Biotech once they receive regulatory approval.
The minister also said the late-stage trial usually involves 30,000 to 40,000 participants. Currently, the vaccines currently in Phase 3 trials are administered by injection, as per the World Health Organization (WHO).
According to India’s Dr Reddy’s Laboratories Ltd and the Russian Direct Investment Fund (RDIF) on Saturday, they have received renewed approval for performing late-stage clinical trials in India of the Russian COVID-19 vaccine.
In the past 24 hours, India’s coronavirus infections surged by another 61,871, data released on Sunday showed.
Bhadrak: Police busted a sex racket operating from a hotel in Odisha's Bhadrak district late… Read More
New Delhi: Delhi Metro Rail Corporation (DMRC) claimed to have scaled the highest point till… Read More
Bhubaneswar: The Odisha Vigilance sleuths on Sunday apprehended Assistant Agriculture Officer lock Technology Manager and… Read More
New Delhi: In a revealing account, Elon Musk has shed light on the dramatic circumstances… Read More
Kolkata: With emotions running high well before Indian and Pakistan clash for Champions Trophy in… Read More
Bhubaneswar: The India Meteorological Department (IMD) has issued nowcast warning for six districts of Odisha… Read More
This website uses cookies.
